Latest filing published 17 Sept 2026 for Sionna Therapeutics, Inc., €19.0M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by RA Capital Healthcare Fund LP span 2 companies, the busiest being Septerna, Inc. and Sionna Therapeutics, Inc. The record holds 2 filings, for trades running from 12 August 2026 to 17 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 17 September 2026 came the latest disclosure, a transaction for €19.0M in Sionna Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations